De Luca HF - Search Results

1

Consensus and Controversial Aspects of Vitamin D and COVID-19.

Bilezikian JP, Binkley N, De Luca HF, Fassio A, Formenti AM, El-Hajj Fuleihan G, Heijboer AC, Giustina A. Bilezikian JP, et al. Among authors: de luca hf. J Clin Endocrinol Metab. 2023 Apr 13;108(5):1034-1042. doi: 10.1210/clinem/dgac719. J Clin Endocrinol Metab. 2023. PMID: 36477486 Review.

2

Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.

Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM, DeLuca HF, Jones G, Munns CF, Bilezikian JP, Giustina A, Binkley N. Sempos CT, et al. Br J Clin Pharmacol. 2018 Oct;84(10):2194-2207. doi: 10.1111/bcp.13652. Epub 2018 Jul 17. Br J Clin Pharmacol. 2018. PMID: 29851137 Free PMC article. Review.

3

Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization.

Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, DeLuca HF, Drezner MK. Binkley N, et al. J Clin Endocrinol Metab. 2004 Jul;89(7):3152-7. doi: 10.1210/jc.2003-031979. J Clin Endocrinol Metab. 2004. PMID: 15240586

4

The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial.

DeLuca HF, Bedale W, Binkley N, Gallagher JC, Bolognese M, Peacock M, Aloia J, Clagett-Dame M, Plum L. DeLuca HF, et al. J Bone Miner Res. 2011 Mar;26(3):538-45. doi: 10.1002/jbmr.256. J Bone Miner Res. 2011. PMID: 20890933 Free article. Clinical Trial.

5

Is the vitamin d receptor found in muscle?

Wang Y, DeLuca HF. Wang Y, et al. Endocrinology. 2011 Feb;152(2):354-63. doi: 10.1210/en.2010-1109. Epub 2010 Dec 29. Endocrinology. 2011. PMID: 21190957

6

2MD, a new anabolic agent for osteoporosis treatment.

Plum LA, Fitzpatrick LA, Ma X, Binkley NC, Zella JB, Clagett-Dame M, DeLuca HF. Plum LA, et al. Osteoporos Int. 2006;17(5):704-15. doi: 10.1007/s00198-005-0036-3. Epub 2006 Feb 21. Osteoporos Int. 2006. PMID: 16491322

7

Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women.

Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL. Ebeling PR, et al. J Clin Endocrinol Metab. 1992 Jul;75(1):176-82. doi: 10.1210/jcem.75.1.1320048. J Clin Endocrinol Metab. 1992. PMID: 1320048

8

Remembrance: discovery of the vitamin D endocrine system.

DeLuca HF. DeLuca HF. Endocrinology. 1992 Apr;130(4):1763. doi: 10.1210/endo.130.4.1547708. Endocrinology. 1992. PMID: 1547708 No abstract available.

9

Osteoporosis and the metabolites of vitamin D.

DeLuca HF. DeLuca HF. Metabolism. 1990 Apr;39(4 Suppl 1):3-9. doi: 10.1016/0026-0495(90)90263-c. Metabolism. 1990. PMID: 2157943 Review.

10

Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD.

Kaufmann M, Gallagher JC, Peacock M, Schlingmann KP, Konrad M, DeLuca HF, Sigueiro R, Lopez B, Mourino A, Maestro M, St-Arnaud R, Finkelstein JS, Cooper DP, Jones G. Kaufmann M, et al. J Clin Endocrinol Metab. 2014 Jul;99(7):2567-74. doi: 10.1210/jc.2013-4388. Epub 2014 Mar 26. J Clin Endocrinol Metab. 2014. PMID: 24670084 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

908 results

Search Page